Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia
Although most guidelines recommend the use of cholinesterase inhibitors (ChEIs) for mild to moderate Alzheimer's Disease, only a small proportion of affected patients receive these drugs. We aimed to study if ...